A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The authors performed a case-cohort study nested within the Atherosclerosis Risk in Communities (ARIC) Study to determine the association between plasma ferritin level and risk of type 2 diabetes mellitus. Persons with incident cases of type 2 diabetes diagnosed over an average follow-up period of 7.9 years (n = 599) were compared with a random sample of the cohort (n = 690). After adjustment for age, gender, menopausal status, ethnicity, center, smoking, and alcohol intake, the hazard ratio for diabetes, comparing the fifth quintile of ferritin with the first quintile, was 1.74 (95% confidence interval: 1.14, 2.65; p-trend < 0.001). After further adjustment for body mass index and components of the metabolic syndrome, the hazard ratio was 0.81 (95% confidence interval: 0.49, 1.34; p-trend = 0.87). From a causal perspective, there are two alternative interpretations of these findings. Elevated iron stores, reflected in elevated plasma ferritin levels, may induce baseline metabolic abnormalities that ultimately result in diabetes. Alternatively, elevated ferritin may be just one of several metabolic abnormalities related to the underlying process that ultimately results in diabetes, rather than a causal factor for diabetes. Longitudinal studies with repeated measurements of glucose and iron metabolism parameters are needed to establish the role of iron stores and plasma ferritin in diabetes development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serum ferritin and body iron stores are strongly associated with diabetes [603,605-609], including prospectively [610]”
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
(1989) · PubMed · Cited by 3,139
Regulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · cited 1×
“In addition, ferritin levels may be increased in response to oxidative stress (31–34), to nitric oxide signaling (34–36), and to several inflammatory cytokines (34, 37, 38)—three mechanisms that are involved in the pathogenesis of the metabolic syndrome (39–41).”
BackgroundFerritin: a cytoprotective antioxidant strategem of endothelium.
Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J. W., & Vercellotti, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37165-0 · Cited by 1,097
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Self-citationCross-Talk Between Iron Metabolism and Diabetes
Fernández-Real, J. M., López-Bermejo, A., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2348 · Cited by 704
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 659
I RON R EGULATORY P ROTEINS AND THE M OLECULAR C ONTROL OF M AMMALIAN I RON M ETABOLISM
Eisenstein, R. S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.627 · Cited by 653
Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
Jiang, R. (2004) · JAMA · doi:10.1001/jama.291.6.711 · Cited by 598
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575
Cited by
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“prospectively [610], while changes in visfatin are also”
BackgroundThe Role of Iron in Diabetes and Its Complications
Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423
“(61) argue that the modest elevations in ferritin levels observed in diabetes may be a consequence or marker rather than the cause of impending insulin resistance and that elevated ferritin may not reflect elevated body iron stores or an intracellular labile iron pool that participates in oxidant injury.”
BackgroundThe role of iron in type 2 diabetes in humans
Rajpathak, S. N., Crandall, J. P., Wylie-Rosett, J., Kabat, G. C., Rohan, T. E., & Hu, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.005 · Cited by 363
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…et al. 2001; Fernández-Real et al. 2002; Ford and Cogswell 1999; Forouhi et al. 2007; He et al. 2007; Hubel et al. 2004; Ishizaka et al. 2005; Jehn et al. 2004, 2007; Kaur et al. 2007; Kiechl et al. 1997; Lee et al. 2006f; Lim et al. 2001; Rayman et al. 2002; Rouault 2006; Salonen et al.…”
Bao, W., Rong, Y., Rong, S., & Liu, L. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-119 · Cited by 259
“[15] (the pooled RR (95% CI) of the remaining studies was 2.”
InfluentialZhao, Z., Li, S., Liu, G., Yan, F., Ma, X., Huang, Z., & Tian, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041641 · Cited by 227
“Among the prospective studies (Figure 11), 4 were inside the 95% bounds, 2 were outliers [10,13] in the Galbraith plot, while among the cross-sectional studies (Figure 12), 3 were within the 95% bounds, and the other 3 were the outliers [20,24,27].”
BackgroundInfluentialSchienkiewitz, A., Schulze, M. B., Hoffmann, K., Kroke, A., & Boeing, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.427 · Cited by 187
“The results of the present study are consistent with findings from previous prospective studies suggesting that high serum ferritin concentrations [4–6, 13] and lower ratios of sTfR to ferritin [5, 7] are associated with increased risk of type 2 diabetes.”
Hooda, J., Shah, A., & Zhang, L. (2014) · Nutrients · doi:10.3390/nu6031080 · Cited by 193
“The positive association between processed red meat and T2D was confirmed by various studies, suggesting that the risk of T2D increases with higher consumption of processed red meat, regardless of gender, age, ethnicity and BMI [66,67,76,78,79].”
BackgroundInfluential(2016) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2016.03.002 · Cited by 177
Atherogenesis and iron: from epidemiology to cellular level
Vinchi, F., Muckenthaler, M. U., Da Silva, M. C., Balla, G., Balla, J., & Jeney, V. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00094 · Cited by 171
“Elevated iron stores reflected by increased plasma ferritin levels are positively correlated with the prevalence of certain diseases such as metabolic syndrome, diabetes and obesity (Jehn et al., 2004, 2007; Lecube et al., 2008; Sun et al., 2008).”
BackgroundThirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
Salomaa, V., Havulinna, A., Saarela, O., Zeller, T., Jousilahti, P., Jula, A., Muenzel, T., Aromaa, A., Evans, A., Kuulasmaa, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010100 · Cited by 169
“Serum ferritin concentration has been found to be an indicator of diabetes risk in the European Prospective Investigation of Cancer (EPIC)Norfolk Study [26], the Nurses Health Study [27] and the Atherosclerosis Risk in Communities (ARIC) Study [28].”
BackgroundInfluentialDevelopment of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort
Kolberg, J. A., Jørgensen, T., Gerwien, R. W., Hamren, S., McKenna, M. P., Moler, E., Rowe, M. W., Urdea, M. S., Xu, X. M., Hansen, T., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1935 · Cited by 164
“Ferritin serves as an antioxidant by binding excess iron, and elevated serum ferritin is a well-established risk factor for future type 2 diabetes (15).”
BackgroundKunutsor, S. K., Apekey, T. A., Walley, J., & Kain, K. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2394 · Cited by 156
“Genetic and environmental factors also determine the levels of circulating ferritin [9], so there is also a possibility that the association between ferritin levels and diabetes is not because of underlying changes in body iron stores.”
BackgroundMethodRole of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Liu, Q., Sun, L. T., Tan, Y., Wang, G., Lin, X., & Cai, L. (2008) · Current Medicinal Chemistry · doi:10.2174/092986709787002862 · Cited by 163
“This correlation was confirmed by subsequently epidemiological studies, i.e.: increased heme iron (derived from animal products) was significantly associated with an increased risk of insulin resistance and type 2 diabetes among a variety of populations, including Asians, Americans and Europeans [53-61].”
BackgroundNovel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
Sattar, N., Wannamethee, S. G., & Forouhi, N. G. (2008) · Diabetologia · doi:10.1007/s00125-008-0954-7 · Cited by 143
“65) between ferritin and diabetes [49].”
Montonen, J., Boeing, H., Steffen, A., Lehmann, R., Fritsche, A., Joost, H.-G., Schulze, M. B., & Pischon, T. (2012) · Diabetologia · doi:10.1007/s00125-012-2633-y · Cited by 124
“Thus, in a recent nested case–control study the association observed between serum ferritin and diabetes risk disappeared after adjustment for components of the metabolic syndrome [13].”
BackgroundResultEpidemiological associations between iron and cardiovascular disease and diabetes
(2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00117 · Cited by 120
High-Molecular-Weight Adiponectin and the Risk of Type 2 Diabetes in the ARIC Study
Zhu, N., Pankow, J. S., Ballantyne, C. M., Couper, D. J., Hoogeveen, R. C., Pereira, M. A., Duncan, B. B., & Schmidt, M. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0716 · Cited by 128
“Adjusted weighted mean (95% CI) of adiponectin in subgroups of the cohort random sample: ARIC study, 1987–1989 Group na Total adiponectin ( g/ml) HMW adiponectin ( g/ml) Ratio of HMW to total adiponectin Meanb (95% CI) P Meanb (95% CI) P Mean (95% CI) P Overall 634 6.41 (6.17–6.67) 2.56 (2.42–2.70) 0.41 (0.41–0.42) Ag…”
MethodInfluentialSelf-citationGestational Diabetes Mellitus in Relation to Maternal Dietary Heme Iron and Nonheme Iron Intake
Qiu, C., Zhang, C., Gelaye, B., Enquobahrie, D. A., Frederick, I. O., & Williams, M. A. (2011) · Diabetes Care · doi:10.2337/dc11-0135 · Cited by 115
“In addition, our findings are supported by studies documenting increased risks of incident GDM (13) or type 2 diabetes (6,11) among individuals with increased levels of serum ferritin, a biological marker of body iron stores.”
ResultRoy, M., Sen, S., & Chakraborti, A. S. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.03.011 · Cited by 115
Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study
Martinelli, N., Traglia, M., Campostrini, N., Biino, G., Corbella, M., Sala, C., Busti, F., Masciullo, C., Manna, D., Previtali, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048250 · Cited by 92
“On the other hand, some prospective studies [16,17] have shown a positive association between baseline levels of ferritin, i.”
Association of iron indices and type 2 diabetes: a meta‐analysis of observational studies
Orban, E., Schwab, S., Thorand, B., & Huth, C. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2506 · Cited by 99
Ruivard, M., Lainé, F., Ganz, T., Olbina, G., Westerman, M., Nemeth, E., Rambeau, M., Mazur, A., Gerbaud, L., Tournilhac, V., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.029 · Cited by 89
“It is likely that iron excess may initiate or, at least, worsen insulin resistance and contribute to the onset of hyperglycemia [4,5].”
BackgroundAssociation of Serum Ferritin and the Development of Metabolic Syndrome in Middle-Aged Korean Men
Park, S. K., Ryoo, J., Kim, M. G., & Shin, J. (2012) · Diabetes Care · doi:10.2337/dc12-0543 · Cited by 103
Ferritin Levels and Risk of Heart Failure—the Atherosclerosis Risk in Communities Study
Silvestre, O. M., Gonçalves, A., Nadruz, W., Claggett, B. L., Couper, D. J., Eckfeldt, J. H., Pankow, J. S., Anker, S. D., & Solomon, S. D. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.701 · Cited by 92
“Use of NSAID, n (%) 14 (9) 69 (10) 27 (11) Postmenopausal status, n (%)‡ 39/130 (30)* 307/401 (75) 123/130 (95)”
Self-citationPretorius, E., Bester, J., Vermeulen, N., Alummoottil, S., Soma, P., Buys, A. V., & Kell, D. B. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0192-5 · Cited by 95
“Iron (increased serum ferritin levels) [64-89].”
Andrews, M., Néstor Soto, I., & Arredondo, M. (2014) · Nutrition · doi:10.1016/j.nut.2014.04.019 · Cited by 98
Biomarkers of body iron stores and risk of developing type 2 diabetes
Rajpathak, S. N., Wylie‐Rosett, J., Gunter, M. J., Negassa, A., Kabat, G. C., Rohan, T. E., Crandall, J., & Diabetes Prevention Program (DPP) Research Group (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00985.x · Cited by 87
Hepcidin expression and iron parameters change in Type 2 diabetic patients
Jiang, F., Sun, Z., Tang, Y., Xu, C., & Jiao, X. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.03.028 · Cited by 84
“Furthermore, a few prospective studies have also reported that relatively high levels of ferritin are associated with an increased of risk of developing DM in apparently healthy individuals [7,8].”
BackgroundHämäläinen, P., Saltevo, J. T., Kautiainen, H., Mäntyselkä, P. T., & Vanhala, M. J. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-116 · Cited by 88
“Previous studies have shown associations between serum ferritin or sTFR and increased risk of type 2 diabetes [18-21].”
Jiang, L., Wang, K., Lo, K. K.-H., Zhong, Y., Yang, A., Fang, X., Akezhuoli, H., Song, Z., Chen, L., An, P., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00495 · Cited by 78
Sun, L., Zong, G., Pan, A., Ye, X., Li, H., Yu, Z., Zhao, Y., Zou, S., Yu, D., Jin, Q., et al. (2013) · Journal of Nutrition · doi:10.3945/jn.113.177808 · Cited by 82
“Two longitudinal studies showed null results (16,17), whereas one study detected the ferritin-diabetes association only in men and not in women (18).”
BackgroundResultWhite, D., & Collinson, A. (2013) · Advances in Nutrition · doi:10.3945/an.113.003681 · Cited by 79
“, 2013 (19) (4,15,20,21,90,96,99,100) 26,339 3391 0 mg/L 222 mg/L 1.”
MethodHe, J., Fang, A., Yu, S., Shen, X., & Li, K. (2020) · Diabetes Care · doi:10.2337/dc19-2202 · Cited by 70
“For example, some studies (11,12) have observed nonlinear relationships between ferritin and diabetes risk; the Atherosclerosis Risk in Communities study (13), followingadjustmentformetabolicsyndrome components, reported a negative association between ferritin and diabetes risk.”
BackgroundYeap, B. B., Divitini, M., Gunton, J. E., Olynyk, J. K., Beilby, J. P., McQuillan, B., Hung, J., & Knuiman, M. W. (2014) · Clinical Endocrinology · doi:10.1111/cen.12529 · Cited by 66
Body iron stores and the risk of type 2 diabetes in middle-aged men
Aregbesola, A., Voutilainen, S., Virtanen, J. K., Mursu, J., & Tuomainen, T. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0145 · Cited by 61
Jung, C. H., Lee, M. J., Hwang, J. Y., Jang, J. E., Leem, J., Park, J., Lee, J.-B., Kim, H., & Lee, W. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075250 · Cited by 56
Raynor, L. A., Pankow, J. S., Duncan, B. B., Schmidt, M. I., Hoogeveen, R. C., Pereira, M. A., Young, J. H., & Ballantyne, C. M. (2012) · Diabetes Care · doi:10.2337/dc12-0609 · Cited by 48
Self-citationPrognosis of patients in a medical intensive care unit
Unal, A. U. (2016) · Northern Clinics of Istanbul · doi:10.14744/nci.2015.79188 · Cited by 47
“In addition to these factors the association of mortality with acute phase reactants as C-reactive protein, albumin, and ferritin has been reported [5-7].”
BackgroundZheng, X., Jiang, T., Wu, H. Y., Zhu, D., Wang, L., Qi, R., Li, M., & Ling, C. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.015743 · Cited by 42
Using Mendelian Randomization to Study the Role of Iron in Health and Disease
Zeitoun, T., & El‐Sohemy, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713458 · Cited by 49
“The absorption of iron is related to iron stored in ferritin, such that absorption is inversely proportional to serum ferritin concentrations [8].”
BackgroundHigh risk of cardiovascular disease in iron overload patients
Meroño, T., Rosso, L. A. G., Sorroche, P. B., Boero, L. E., Arbelbide, J. A., & Brites, F. D. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02429.x · Cited by 43
Circulating ferritin concentrations and risk of type 2 diabetes in Japanese individuals
Akter, S., Nanri, A., Kuwahara, K., Matsushita, Y., Nakagawa, T., Konishi, M., Honda, T., Yamamoto, S., Hayashi, T., Noda, M., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12617 · Cited by 38
“et al.(22) reported that the ferritin–diabetes association disappeared after additional adjustment for components of metabolic syndrome.”
BackgroundThe association of biomarkers of iron status with mortality in US adults
Menke, A., Muntner, P., Fernández‐Real, J. M., & Güallar, E. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.11.011 · Cited by 38
Bonfils, L., Ellervik, C., Friedrich, N., Linneberg, A. R., Sandholt, C. H., Jørgensen, M. E., Jørgensen, T., Hansen, T. F., Pedersen, O. B., & Allin, K. H. (2014) · Diabetologia · doi:10.1007/s00125-014-3469-4 · Cited by 45
“In the fasting state, elevated serum ferritin levels have been found to be associated with levels of insulin and glucose [16, 22, 29], and a few studies of up to 1,013 participants using OGTTs, IVGTTs or various clamps have shown an association between elevated ferritin levels and decreased insulin sensitivity [29–32].”
BackgroundUysal, A., Simavlı, S. A., Kaygusuz, İ., Gümüş, İ. İ., Yılmaz, S., Yıldırım, M., & Uysal, S. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.770462 · Cited by 42
“in apparently healthy individuals [4].”
Getting the iron out: Phlebotomy for Alzheimer’s disease?
Dwyer, B. E., Zacharski, L. R., Balestra, D. J., Lerner, A. J., Perry, G., Zhu, X., & Smith, M. A. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.029 · Cited by 35
“T2DM increases risk for AD and for mild cognitive impairment (MCI), the transitional stage between normal cognition and AD [1,23], and increased stored iron is associated with risk for T2DM [24–27].”
BackgroundSerum ferritin, diabetes, diabetes control, and insulin resistance
Zhan, Y., Tang, Z., & Yu, J. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0656-1 · Cited by 32
“Our results were consistent with the aforementioned studies and those conclusions from studies which collected data from Caucasian descent [17–22].”
BackgroundResultAssociation between Iron Status and Incident Type 2 Diabetes: A Population-Based Cohort Study
Díaz‐López, A., Iglesias‐Vázquez, L., Pallejà-Millán, M., Rey‐Reñones, C., Flores‐Mateo, G., & Arija, V. (2020) · Nutrients · doi:10.3390/nu12113249 · Cited by 36
“Similar findings were obtained in American studies, including The Atherosclerosis Risk in Communities (ARIC) Study involving 15,792 participants [9]; a large prospective case-control study nested in the Nurses’ Health Study cohort, which assessed 1414 women for 10 years [6]; and the Aerobic Center Longitudinal Study (…”
ResultArija, V., Fernández‐Cao, J. C., Basora, J., Bulló, M., Aranda, N., Estruch, R., Martínez‐González, M. Á., & Salas‐Salvadó, J. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514002852 · Cited by 36
“ships between SF and the risk of T2DM, few studies had adjusted for fasting glucose levels((8)) and other components of the metabolic syndrome (MetS)((5)), which are the parameters”
BackgroundMethodLing, C., Li, Y., Zhang, F., Zhang, S., Zhou, X., & Ji, L. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.001 · Cited by 31
Dekker, L. H., Nicolaou, M., van der A, D. L., Busschers, W. B., Brewster, L. M., Snijder, M. B., Stronks, K., & van Valkengoed, I. G. M. (2012) · Diabetes Care · doi:10.2337/dc12-1243 · Cited by 41
“Unfortunately, other multiethnic studies have not considered differential sex effects across ethnic groups (10,19,20).”
BackgroundResultJiang, L., Bao, W., Zhang, T., Zhou, Y., Yang, H., Jia, H., Wang, R., Cao, Y., & Xiao, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190310 · Cited by 30
Mottelson, M., Glenthøj, A. B., Nordestgaard, B. G., Ellervik, C., Petersen, J., Bojesen, S. E., & Helby, J. (2024) · Blood · doi:10.1182/blood.2023022235 · Cited by 34
Muñoz‐Santos, C., Guilabert, A., Moreno, N., Giménez, M., Darwich, E., To‐Figueras, J., & Herrero, C. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10401.x · Cited by 29
Insulin Sensitivity, Vascular Function, and Iron Stores in Voluntary Blood Donors
Zheng, H., Patel, M., Cable, R. G., Young, L. H., & Katz, S. D. (2007) · Diabetes Care · doi:10.2337/dc07-0748 · Cited by 31
Serum ferritin and incident cardiometabolic diseases in Scottish adults
Suárez‐Ortegón, M. F., McLachlan, S., Fernández‐Real, J. M., Tuomainen, T., Aregbesola, A., & Wild, S. H. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01450-7 · Cited by 30
Yogic practice and diabetes mellitus in geriatric patients
Rani, K., & Sreekumaran, E. (2013) · International Journal of Yoga · doi:10.4103/0973-6131.105946 · Cited by 33
“[6]”
Yin, J., Chu, H., Qin, S., Qi, H., & Hu, M. (2021) · Sensors · doi:10.3390/s21217355 · Cited by 25
“[4] confirmed that elevated iron could lead to abnormal baseline metabolism.”
BackgroundYang, A., Zhao, J. Y., Lu, M., Gu, Y., Zhu, Y., Chen, D., & Fu, J. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13080766 · Cited by 29
“Moreover, several studies have shown that increased iron stores in the general population is accompanied by an elevated incidence of diabetes [19,20].”
Wang, Y., Koh, W., Yuan, J., & Pan, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.012 · Cited by 25
Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis
Casanova-Esteban, P., Guiral, N., Andres, E. M., Gonzalvo, C., Mateo‐Gállego, R., Giraldo, P., Páramo, J. A., & Civeira, F. (2010) · Metabolism · doi:10.1016/j.metabol.2010.07.035 · Cited by 28
“Moreover, there is a strong association between deposition of iron, measured by plasma ferritin concentrations, and the risk of type 2 diabetes mellitus and metabolic syndrome [7-9], with both situations characterized by peripheral insulin resistance [10-13].”
BackgroundPrevalence of Anemia in both Developing and Developed Countries around the World
Prasanth, R. (2017) · doi:10.5005/jp-journals-10065-0009 · Cited by 30
Gao, S., Zhao, D., Qi, Y., Wang, M., Zhao, F., Sun, J., & Liu, J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.013 · Cited by 24
Genetic Determinants for Body Iron Store and Type 2 Diabetes Risk in US Men and Women
He, M., Workalemahu, T., Manson, J. E., Hu, F. B., & Qi, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040919 · Cited by 25
“Prospective epidemiology studies have shown consistent associations between body iron store, assessed by serum ferritin or transferrin receptors to ferritin ratio, and an increased risk of T2D [3–7].”
Mutations inHFECausing Hemochromatosis Are Associated with Primary Hypertriglyceridemia
Solanas-Barca, M., Mateo‐Gállego, R., Calmarza, P., Jarauta, E., Bea, A. M., Cenarro, A., & Civeira, F. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0814 · Cited by 25
“Elevated iron storage is positively associated with the prevalence of the metabolic syndrome (12, 13), diabetes (13, 14), and obesity (15) by mechanisms not fully understood, and interestingly, all of them are highly associated with the development of HTG.”
BackgroundLiu, B., Xuan, X.-M., Liu, J., Fang-ning, L., & Yin, F. (2015) · International Journal of Endocrinology · doi:10.1155/2015/642194 · Cited by 21
Insulin resistance: an emerging link in Alzheimer’s disease
Medhi, B., & Chakrabarty, M. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1454-1 · Cited by 24
The complementary roles of iron and estrogen in menopausal differences in cardiometabolic outcomes
Ahanchi, N. S., Khatami, F., Llanaj, E., Quezada‐Pinedo, H. G., Dizdari, H., Bano, A., Glišić, M., Eisenga, M. F., Marques-Vidal, P. M., & Muka, T. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.03.026 · Cited by 22
Yu, F.-J., Huang, M., Chang, W., Chung, H., Wu, C.-Y., Shin, S., & Hsu, C. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000339265 · Cited by 21
Schulze, M. B., & Hu, F. B. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_66 · Cited by 21
Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity
López-Calderón, C., Palacios, R., Cobo, A., Nuño, E., Ruiz, J., Márquez, M., & Santos, J. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414539669 · Cited by 22
Ironing out the Details: Untangling Dietary Iron and Genetic Background in Diabetes
Miranda, M. A., & Lawson, H. A. (2018) · Nutrients · doi:10.3390/nu10101437 · Cited by 19
Andrews, M., & Olguín, M. A. (2014) · PubMed · doi:10.3305/nh.2014.30.3.7647 · Cited by 20
Meng, G., Yang, H., Bao, X., Zhang, Q., Liu, L., Wu, H. Y., Du, H., Xia, Y., Shi, H., Guo, X., et al. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.07.028 · Cited by 18
Nakagawa, T., Muramoto, Y., Hori, M., 修一, 三., Marubayashi, T., & Nakagawa, K. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.08.004 · Cited by 17
Donation intensity and metabolic syndrome in active whole‐blood donors
Peffer, K., Verbeek, A. L. M., Swinkels, D. W., Geurts-Moespot, A. J., den Heijer, M., & Atsma, F. (2015) · Vox Sanguinis · doi:10.1111/vox.12258 · Cited by 20
Dahyaleh, K., Sung, H. K., Prioriello, M., Palanivel, R., Lam, N. H., Kim, J. B., Gross, S. M., & Sweeney, G. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30240 · Cited by 16
“…backgrounds and ages, those with higher serum ferritin levels were more likely to develop T2D when compared to those with lower levels of iron (Forouhi et al., 2007; Fumeron et al., 2006; Jehn et al., 2007; Jiang et al., 2004; Rajpathak et al., 2009; Salonen et al., 1998; Swaminathan et al., 2007).”
BackgroundZhou, B., Liu, S., & Yuan, G. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.550011 · Cited by 17
Vitamin D decreases pancreatic iron overload in type 2 diabetes through the NF-κB-DMT1 pathway
Zhao, Y., Mei, G., Zhou, F., Kong, B., Chen, L., Chen, H., Wang, L., Tang, Y., & Yao, P. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108870 · Cited by 16
Serum Ferritin and Risk of the Metabolic Syndrome in Some Korean Rural Residents
Ryu, S. Y., Kim, K. S., Park, J., Kang, M. G., & Han, M. A. (2008) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2008.41.2.115 · Cited by 16
“1⁄2, 3⁄4n¿ÀK2Á¦Â N6ÃÄÅYZ® ̄1⁄4Æ [4-6], ̄¢Ç [7], qMJ¢¶ [8], ¤¥§ ̈7¢¦ 6 ¶ [2], ¥R ÈÉ [9,10]7a #OJ LÊYZËÌq ̄_.”
Liu, P. J., Yao, A., Chen, X. Y., Liu, Y.-P., Ma, L., & Hou, Y. X. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02169-w · Cited by 13
Wang, M., Liu, Y., Gui, H., Ma, G., Li, B., Zhang, Z., Yu, G., Wu, A., Xu, X., & Zhang, D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176303 · Cited by 13
Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx® Diabetes Risk Score
Kolberg, J. A., Gerwien, R. W., Watkins, S. M., Wuestehube, L. J., & Urdea, M. S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.63 · Cited by 11
Munasinghe, L. L., Ekwaru, J. P., Mastroeni, M. F., Mastroeni, S. S. D. B. S., & Veugelers, P. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213260 · Cited by 12
Zafar, U., Qureshi, H. J., & Imran, M. J. (2015) · PubMed · Cited by 9
Zhou, F., Zhao, Z., Tian, L., Zheng, T., Gao, Y., Chen, T., Yan, F., & Tian, H. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0393-5 · Cited by 9
“They concluded that elevated ferritin might not be a causal factor for T2DM , but a biomarker of metabolic ab - normalities related to the pathogenesis of T2DM [ 22 ] , which is consistent with our findings .”
BackgroundResultInfluentialFeng, J., Shan, X., Wang, L., Lu, J., Cao, Y., & Yang, L. (2023) · Nutrients · doi:10.3390/nu15081935 · Cited by 10
“With the exception of a few studies that found no association between SF and T2DM risk [6], most cross-sectional and prospective studies have demonstrated a positive association between SF levels and T2DM in different populations [10,23–26].”
ResultBody iron stores in middle-aged North Indian patients with type 2 diabetes and obesity
Gupta, M., Palta, A., Singh, R. B., & Lehl, S. S. (2014) · Journal of Mid-life Health · doi:10.4103/0976-7800.133991 · Cited by 8
“[9] These observations have been confirmed and reiterated in many other ethnic groups worldwide.[10-13] Raj and Rajan from India have published their data on 86 diabetic patients and found a positive correlation between SF, fasting blood sugar and HbA1c.”
BackgroundÉléments-trace essentiels en nutrition humaine: chrome, sélénium, zinc et fer
Roussel, A.-M., & Hininger‐Favier, I. (2009) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(09)49501-5 · Cited by 14
Martinelli, N., Traglia, M., Campostrini, N., Biino, G., Corbella, M., Sala, C. F., Busti, F., Masciullo, C., Manna, D., Previtali, S., et al. (2013) · PLoS ONE · doi:10.1371/annotation/233a5ac3-8118-4bdc-a139-950223506864 · Cited by 7
Naeem, M. T., Schipf, S., Bülow, R., Werner, N. L., Dörr, M., Lerch, M. M., Kühn, J., Rathmann, W., Nauck, M. A., Markus, M. R. P., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.02.013 · Cited by 6
Surcharges en fer d’origine génétique et hépatosidérose dysmétabolique
Ruivard, M. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.05.004 · Cited by 6
Yoon, H. J., Go, J. S., Kim, K. U., & Lee, K. W. (2016) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2016.48.4.287 · Cited by 7
“Serum ferritin is used as a clinical biomarker to evaluate iron status, and elevated serum ferritin concentration has been reported to be associated with the risk factors of cardiovascular disease such as diabetes mellitus, insulin resistance, and hypertension [6-9].”
BackgroundIncidental risk for diabetes according to serum ferritin concentration in Korean men
Kim, S., Park, S. K., Ryoo, J., Choi, J., Hong, H. P., Park, J. H., Suh, Y. J., & Byoun, Y.-S. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.024 · Cited by 8
Ware, W. R. (2010) · Cited by 6
Khatami, F., Lange, T., Groothof, D., Ahanchi, N. S., Quezada‐Pinedo, H. G., Raeisi‐Dehkordi, H., de Borst, M. H., Marques-Vidal, P. M., Mohan, S., Prabhakaran, D., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae098 · Cited by 4
“Some have only shown an association between ferritin and diabetes incidence in females, some in males, and others in both sexes [14, 15, 36, 48].”
BackgroundPourabbas, A., Fallah, F., Mahdavi, R., & Aliasgarzadeh, A. (2013) · PubMed Central · Cited by 6
Schulze, M. B., & Hu, F. B. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_66-1 · Cited by 6
Metadata
- Authors
- Jehn, M. L., Guallar, E., Clark, J. M., Couper, D., Duncan, B. B., Ballantyne, C. M., Hoogeveen, R. C., Harris, Z. L., & Pankow, J. S.
- Affiliations
- Johns Hopkins University (US)
- University of North Carolina at Chapel Hill (US)
- Universidade Federal do Rio Grande do Sul (BR)
- Baylor College of Medicine (US)
- University of Minnesota (US)
- ORCID
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-25
- Volume
- 165
- Issue
- 9
- Pages
- 1047-1054
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2149560259
- Cited by
- 136
- References
- 50
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 7 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 2 · 2017: 8 · 2016: 7 · 2015: 8 · 2014: 16 · 2013: 16 · 2012: 12
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc55021-47-0-1, n01hc55020-39-0-0, n01hc55016-37-0-0, n01hc055022-024, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Heart, Lung, and Blood Institute (N01-HC55022, N01-HC-55018, N01 HC 55020, N01 HC 55019, N01-HC55016, N01‐HC‐55015, N01-HC55021)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- plasma ferritin, type 2 diabetes, iron stores, incident diabetes risk, metabolic syndrome, body mass index, causal interpretation, iron metabolism, Atherosclerosis Risk in Communities Study
- MeSH terms
- Arteriosclerosis, Diabetes Mellitus, Type 2, Female, Ferritins, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Body Mass Index, Incidence, Proportional Hazards Models, Case-Control Studies, Risk Assessment, Iron Overload
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.